Response of metastatic breast cancer to trastuzumab?

被引：18

作者：

Barnes, DM ^{[1
]}

Miles, DW

机构：

[1] Guys Hosp, Imperial Canc Res Fund, Breast Pathol Lab, London SE1 9RT, England

[2] Guys Hosp, Imperial Canc Res Fund, Breast Biol Grp, London SE1 9RT, England

来源：

LANCET | 2000年 / 355卷 / 9199期

关键词：

D O I：

10.1016/S0140-6736(99)00430-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：160 / 161

页数：2

共 16 条

[1] Allred DC, 1998, MODERN PATHOL, V11, P155
[2] Phase II study of weekly intravenous recombinant humanized Anti-p185(HER2) monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast
Baselga, J
Tripathy, D
Mendelsohn, J
Baughman, S
Benz, CC
Dantis, L
Sklarin, NT
Seidman, AD
Hudis, CA
Moore, J
Rosen, PP
Twaddell, T
Henderson, IC
Norton, L
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) : 737 - 744
[3] Brenner T L, 1999, J Am Pharm Assoc (Wash), V39, P236
[4] Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease
Cobleigh, MA
Vogel, CL
Tripathy, D
Robert, NJ
Scholl, S
Fehrenbacher, L
Wolter, JM
Paton, V
Shak, S
Lieberman, G
Slamon, DJ
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 2639 - 2648
[5] Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer
Goldenberg, MM
[J]. CLINICAL THERAPEUTICS, 1999, 21 (02) : 309 - 318
[6] HANCOCK MC, 1991, CANCER RES, V51, P4575
[7] MONOCLONAL-ANTIBODIES DIRECTED TO THE ERBB-2 RECEPTOR INHIBIT IN-VIVO TUMOR-CELL GROWTH
HARWERTH, IM
WELS, W
SCHLEGEL, J
MULLER, M
HYNES, NE
[J]. BRITISH JOURNAL OF CANCER, 1993, 68 (06) : 1140 - 1145
[8] Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer
Jacobs, TW
Gown, AM
Yaziji, H
Barnes, MJ
Schnitt, SJ
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) : 1974 - 1982
[9] Specificity of HercepTest in determining HER-2/neu status of breast cancers using the united states food and drug administration-approved scoring system
Jacobs, TW
Gown, AM
Yaziji, H
Barnes, MJ
Schnitt, SJ
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) : 1983 - 1987
[10] MCKENZIE SJ, 1989, ONCOGENE, V4, P543

← 1 2 →